Silver Sponsor of Virtual Friends for Life Orlando 2020
Virtual Friends for Life Orlando 2020 Booth
Live Exhibition Hall Hours (All Times Eastern US)
Wednesday, July 15: 6:00 - 8:00 pm
Thursday, July 16: 8:00 - 9:00 am, 12:30 - 1:30 pm, 4:00 - 5:00 pm
Friday, July 17: 8:00 - 9:00 am and 12:30 - 2:00 pm
Wednesday Evening Virtual Booth Sessions
Thursday Virtual Booth Sessions
Friday Virtual Booth Sessions
We’re excited to announce that Control-IQ technology for the t:slim X2 insulin pump is now cleared for ages 6 and up! Click to learn more about this system and how easy it is to learn and use, whether you’re a kid, parent, or caregiver.
RX ONLY. BOXED WARNING: Should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. For boxed warning and safety information, see tandemdiabetes.com/safetyinfo.
Learn More About t:slim and Control IQ
The T1D Community is Excited About Control-IQ Technology for the t:slim X2 Insulin Pump
Across the T1D community, people are sharing how easy control can be with Control-IQ™ advanced hybrid closed-loop technology for the t:slim X2™ insulin pump.
See How Easy Control Can Be with Control-IQ Technology for the t:slim X2 Insulin Pump
Trying to keep your blood sugar in range can be stressful and time consuming, but it can be easier. But don’t take our word for it. Instead, see how Control-IQ™ advanced hybrid closed-loop technology for the t:slim X2™ insulin pump helps Sally, Lindsey, Leslie, and Caitlin reduce the burden of managing their diabetes by predicting and helping to prevent highs and lows.
How Control-IQ Technology Works on the t:slim X2 Insulin Pump
This video provides a brief overview of how Control-IQ™ technology works with your t:slim X2™ insulin pump to help manage your diabetes on a day-to-day basis by predicting and helping prevent both highs and lows. The video explains how Control-IQ advanced hybrid closed-loop technology is designed to help increase time in range (70-180 mg/dL)* using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly; including delivery of automatic correction boluses† as needed.
*As measured by CGM
† If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value. It will do this up to once per hour as needed.
Resources About t:slim and Control IQ
Zoom Backgrounds
Important Safety Information:
RX ONLY.
Indications for Use:
t:slim X2 insulin pump
The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use with NovoLog or Humalog U-100 insulin.
Control-IQ technology
Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Contraindications and Warnings:
WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea.
Users of the t:slim X2 pump and Control-IQ technology must:
- be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use;
- test blood glucose levels as recommended by their healthcare provider;
- demonstrate adequate carb-counting skills;
- maintain sufficient diabetes self-care skills;
- see healthcare provider(s) regularly; and
- have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders;
The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment.
Visit tandemdiabetes.com/safetyinfo for additional important safety information.
